As expected, our data from DZNep therapy in tongue cancer xenograft model indicated that DZNep delivery efficiently depleted intratumoral EZH2, significantly inhibited the tumor growth by reducing cell proliferation and triggering cell apoptosis. The gene discussed is EZH2; the disease is neoplasm.